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Abstract
Influenza viruses pose a significant health risk and annually impose a great cost to patients and the health care
system. The molecular determinants of influenza severity, often exacerbated by secondary bacterial infection, are
largely unclear. We generated a novel outbred mouse model of influenza virus, Staphylococcus aureus, and co-
infection utilizing influenza A/CA/07/2009 virus and S. aureus (USA300). Outbred mice displayed a wide range of
pathologic phenotypes following influenza virus or co-infection ranging broadly in severity. Influenza viral burden
positively correlated with weight loss although lung histopathology did not. Inflammatory cytokines including IL-6,
TNF-α, G-CSF, and CXCL10 positively correlated with both weight loss and viral burden. In S. aureus infection,
IL-1β, G-CSF, TNF-α, and IL-6 positively correlated with weight loss and bacterial burden. In co-infection, IL-1β
production correlated with decreased weight loss suggesting a protective role. The data demonstrate an approach to
identify biomarkers of severe disease and to understand pathogenic mechanisms in pneumonia.
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Introduction
Influenza represents a highly contagious family of respiratory
viruses that infect between 5-20% of the US population and
account for as many as 30,000 deaths annually. However,
influenza causes a broad range of disease outcomes ranging
from very mild infection to death. The influenza A virus H1N1
has been the cause of two global pandemics over the last
century. The 1918 H1N1 pandemic infected nearly one-third of
the world population (about 500 million cases) with mortality
rates greater than 2.5%, much higher than usual seasonal
outbreaks (0.1%) [1]. Mortality during the 1918 influenza
pandemic occurred primarily in two waves: first, an acute
response to virus, resulting in excessive inflammatory mediator
production and diffuse alveolar damage resulting in acute
respiratory distress; second, for 20% of those infected,
development of secondary bacterial pneumonia [2]. Recent
work characterizing the 1918 influenza outbreak has identified
secondary bacterial infection as a key contributor to mortality
[3]. The primary pathogen involved in secondary pneumonia
was Streptococcus pneumoniae. Similar co-infection data were
observed during the recent 2009 novel H1N1 pandemic. Unlike
seasonal influenza virus strains, novel H1N1 infections resulted
in increased morbidity and mortality in young adults in addition
to the very young and very old. In 2009 alone, approximately
61 million were infected in the US with 274,000 hospitalizations
and 12,470 deaths according to the Center for Disease Control
CDC (http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm)
[4]. In a CDC study of mortalities in young adults (median age
31), 29% were positive for secondary bacterial infection;
among those, 45% were S. pneumoniae positive and 33%
were Staphylococcus aureus positive [5].
Exacerbation of influenza A virus pneumonia by secondary
S. pneumoniae or S. aureus infection in mice has been
demonstrated [6,7]. Influenza virus infection has been shown to
enhance susceptibility to secondary bacterial infections by
multiple pathways including altering bacterial adhesions, TLR
expression and pathogen-associated molecular pattern
(PAMP) receptors on epithelial cells [8-11]. Induction of type I
(IFNα and IFNβ) or type II (IFNγ) interferons by influenza A
virus was shown to inhibit clearance of pneumococcal and S.
aureus pneumonia in mice [12-14]. Recently, we and others
have shown that preceding influenza virus infection suppresses
subsequent TH17 pathway activation by secondary bacterial
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infection [12,15]. These data indicate a mechanism by which
influenza A virus infection enhances the lung’s susceptibility to
secondary bacterial pneumonia. Furthermore, many
investigators have demonstrated a synergism between
influenza A virus and S. aureus in lung injury [16-18]. Bacterial
sepsis represents a significant cause of death in the United
States (200,000 deaths annually) and the primary cause and
location of sepsis is gram-positive bacteria in the lung [19,20].
Several studies have temporally linked the onset of influenza A
virus infection and the incidence of S. aureus pneumonia [21].
Furthermore, the presence of preceding influenza-like
symptoms was shown to correlate with increased mortality in
methicillin-resistant S. aureus (MRSA) infected patients [22]. A
recent study of children with complicated pneumonia showed
that S. aureus was the most prevalent bacterial infection
associated with influenza A virus and that this co-infection
resulted in increased intensive care admission, ventilator
usage, cost of stay, and mortality [23]. These data suggest that
a primary severe consequence of influenza A virus infection is
secondary S. aureus pneumonia.
Influenza virus infection has been modeled in mice for many
years in order to gain insight into disease pathogenesis and the
host response. The majority of these studies have been
performed in inbred mouse lines that exhibit strain specific
characteristics in response to influenza virus. While these
studies have proven informative in many critical areas, the
intrastrain uniformity of influenza virus infection has limited the
determination of the molecular signature of severe disease.
Outbred mouse lines have been utilized for influenza virus
vaccine studies for the last 25 years. However, very little is
known about the characteristics of severe versus mild disease
in this context. In addition, there are many known problems
regarding classic outbred mouse lines in terms of defining and
tracking allelic diversity [24]. The goal of this study was to
utilize a novel outbred mouse line (Jackson Laboratories
Diversity Outbred) to examine both mild and severe influenza
virus infection. With this approach, the critical hallmarks of




Age-matched male Diversity Outbred mice (8 to 10 weeks)
were purchased from Jackson Laboratories (Bar Harbor, ME).
In the initial influenza virus study, mice ranged in weight from
17.4 to 28.0 g. In the co-infection studies mice ranged in weight
from 21.5 to 37.6 g. All animal studies were approved by the
Institutional Animal Care and Use Committee of the University
of Pittsburgh protocol number 1108659. All invasive
procedures were performed under isoflurane or pentobarbital
anesthesia to ameliorate animal distress.
Influenza virus and bacterial infection
Mice were infected with 1x106 pfu of influenza A/California/
07/2009 virus by intranasal inoculation. Influenza virus was
grown in chicken eggs and viral hemagglutinin and
neuraminidase were sequenced to ensure no mutations. The
influenza virus dose was chosen based on preliminary studies
in C57BL/6 mice that resulted in 15-20% weight loss mimicking
severe influenza virus infection. Mice were the harvested either
five or eight days after influenza virus infection. In bacterial
infections studies, mice received 1x108 cfu of MRSA (USA300)
by intranasal inoculation. Tissues were harvested two days
after bacterial infection. For co-infection studies mice received
influenza virus then were challenged with S. aureus six days
after viral infection, mice were then harvested an additional two
days later. All mice were tracked for morbidity by measuring
weight loss daily post-infection. For influenza virus studies,
“high” weight loss was defined as losing more than 15% initial
weight while “low” weight loss refers to less than 5% weight
loss. For S. aureus infected mice, “low” refers to less than 3%
weight loss, high weight loss refers to greater than 5% loss
from starting weight.
Assessment of inflammation
On harvest day, the lungs were bronchoalveolar lavaged
(BAL) with sterile PBS. BAL inflammatory cells were examined
by total cell counts. BAL protein concentration was analyzed by
bicinchoninic acid protein assay (Thermo Fisher Scientific,
Rockford, IL). Serum was collected by transection of the
inferior vena cava and renal artery into heparin treated tubes.
The left lung was isolated and fixed with 10% neutral buffered
formalin for histology. The upper right lung lobe was
homogenized in PBS for bacterial colony counts, viral burden
by qRT-PCR, and cytokine analysis by Lincoplex (Millipore,
Billerica, MA). The middle and lower right lung lobes were snap
frozen in liquid N2 for isolation of total RNA.
Gene expression analysis
Total RNA was isolated from lung tissue using the Absolutely
RNA Miniprep Kit (Agilent, Santa Clara, CA). For qualitative
real-time PCR analysis (qRT-PCR), cDNA was generated
using an iScript cDNA Synthesis Kit (Biorad, Hercules, CA).
qRT-PCR was performed using Assay On Demand primer and
probe sets for target genes of interest (Life Technologies,
Grand Island, NY) with the Applied Biosystems 7900 machine
(Life Technologies). Gene expression was quantified using
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) as a
lung housekeepeing gene. Data were converted to relative
expression levels using the ΔΔCT (cycles to threshold) method.
Influenza virus matrix gene expression was detected by using
the following primers/probe - Forward primer: 5'
GGACTGCAGCGTAGACGCTTT 3' Reverse primer: 5'
CATCCTGTTGTATATGAGKCCCAT 3' Probe: 5' 6FAM-
CTMAGYTATTCWRCTGGTGCACTTGCC-BHQ 3'. The term
“high viral burden” refers to mice with a 10-fold elevated matrix
gene expression versus a “low burden” animal in the study
group and represents relative changes in burden.
Histologic analyses
Formalin-fixed lung tissue was embedded in paraffin and cut
into 5 μm sections. Sections were then stained with
hematoxylin and eosin for analysis. Histologic scoring of
inflammation was performed by a trained pathologist. Slides
were blinded and scored for parenchymal, perivascular, and
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peribronchial inflammation using a 1 to 4 scale with 4 being the
most severe.
Statistics
Correlation analysis was performed using Pearson’s product-
moment correlation coefficient (R) to determine the degree of
significance using the Microsoft Excel software package
(Redmond, WA). Statistical significance was set at p-value <
0.05.
Results
Generation of a novel mouse model of pandemic
influenza virus severity
In order to best examine the molecular phenotype of
influenza virus infection severity in mice, we chose to develop a
novel model for influenza virus infection in a newly available
outbred mouse line. To do this, we utilized Jackson
Laboratories Diversity Outbred (JDO) mice. Jackson
Laboratories has recently introduced this novel line as an
improvement on existing outbred colonies. JDO mice were
produced by a novel outbreeding strategy designed to preserve
founder genomes and avoids allelic loss. The JDO founders
were derived from mice from the Collaborative Cross (CC) [25].
The CC is a large group of inbred mouse strains derived from
an eight-way cross using a set of mice that included three wild-
derived strains. Recent work using the CC mice has examined
severity markers in the context of mouse influenza (A/PR/8/34)
virus infection [26,27]. We have chosen the JDO model herein
to maximize allelic variation throughout the genome. Another
advantage is that Jackson Laboratories offers an array chip to
map over 620,000 single nucleotide polymorphisms (SNP).
This would allow us in the future to perform SNP analysis on
mice with interesting phenotypes in response to influenza virus
and/or co-infection.
We infected 30 male JDO mice with influenza virus
(pandemic H1N1 CA/07/2009, 1x106 pfu, intranasally) for five
days. Weight loss was used as a primary endpoint for
morbidity. Inbred mouse strains generally provide limited
variation between animals. JDO mice displayed a much larger
range of weight loss phenotypes, from 108.4 to 73.0% of
starting body weight (Figure 1A). We observed clear
populations of mice that had very little or no weight loss. By
day five, 10 of 30 mice had greater than 95% of the original
body weight. On the other hand, 11 of 30 mice were below
80% of their initial weight. These findings indicate clear
groupings of mice into mild and severe phenotypes and confirm
that the JDO mouse line had a variable response to influenza
virus infection. Weight loss on day 3 significantly correlated
with weight loss in the same animal by day five (R = 0.888, p <
0.005). Next, we examined if starting weight had an impact on
eventual influenza outcome. We saw a significant positive
correlation between starting weight and weight loss percentage
(Figure 1B). The mice used in the study were age matched 8
week old mice. These data suggest that larger, heartier
animals would be predicted to suffer reduced morbidity
compared to smaller animals. From the original 30 mouse
study, we harvested 14 mice on day five for further analysis.
We compared bronchoalveolar lavage (BAL) cell counts and
protein concentrations with weight loss percentage.
Interestingly, BAL total inflammatory cell counts did not
significantly correlate with weight loss (Figure 1C). However,
BAL protein concentration significantly negatively correlated
with starting weight percentage (Figure 1D). These data
indicate that increased BAL protein concentration is predictive
of increased weight loss and thus morbidity.
Weight loss and viral burden significantly correlate
A possible explanation for the differences seen in weight loss
is variable viral burden in mice. RNA was isolated from
influenza virus infected lungs for qRT-PCR analysis. Influenza
virus burden was determined by qRT-PCR for viral matrix
protein specific for H1N1 CA/07/2009. Viral M protein RNA was
detectable in all mice in the study on both day 5 and 8 post
infection. We found a significant correlation between weight
loss and viral burden (Figure 2), both five and eight days after
infection. Despite this correlation, there were examples of mice
with similar viral burden, but disparate weight loss. Thus, viral
burden alone does not explain the range of morbidity
phenotypes observed.
Lung histopathology demonstrates a broad range of
disease phenotypes
In order to determine if weight loss and/or viral burden
directly related to lung pathogenesis, lungs were fixed and
analyzed by light microscopy. Interestingly, the degree of lung
injury observed was variable and did not directly reflect weight
loss or viral burden at day five post infection. Mice with similar
viral burden, but different weight loss displayed similar amounts
of parenchymal inflammation (Figure 3A,B). Further, mice with
similar weight loss, but different viral burden also showed
similar amounts of parenchymal inflammation (Figure 3C,D). In
addition to these findings, individual mice often had surprising
histologic phenotypes. For example, a mouse with severe
weight loss and high viral burden had less lung inflammation
(Figure 3E). Conversely, a mouse with no weight loss and very
low viral burden had significant parenchymal consolidation
(Figure 3F). Further, histologic lung inflammation
(parenchymal, R = 0.0529; peribronchial, R = -0.3413;
perivascular, R = -0.1428) did not significantly correlate with
weight loss (Figure 3G). In addition, lung inflammation did not
correlate with viral burden (parenchymal, R = -0.1304;
peribronchial, R = 0.2827; perivascular, R = 0.2161). These
data demonstrate that diverse lung pathologic phenotypes
following influenza virus do not directly correlate to weight loss
(morbidity) or viral burden. In addition, this range of phenotypes
displayed in this novel model may better reflect the diversity of
human responses to influenza virus.
Cytokine production correlates with weight loss and
viral burden
Lung and serum cytokine levels may serve as a biomarker
for influenza severity. To examine this, we first prepared lung
homogenate from the day five influenza virus infected mice and
analyzed inflammatory cytokines by Lincoplex. We measured
19 cytokines and did not find a significant correlation between
Novel Model of Pandemic Influenza and Co-Infection
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any cytokine and weight loss percentage. However, we did
detect a trend towards a positive correlation between G-CSF
and viral burden (Figure 4A). Next, we examined serum
cytokine levels and determined that CXCL10 (IP-10)
significantly correlated with viral burden (positive) and starting
weight percentage (negative) (Figure 4B,C). Interestingly,
another CXCR3 ligand, CXCL9, positively correlated with
starting weight percentage (Figure 4D). These data show that a
limited number of serum cytokines may be linked to influenza
morbidity and burden.
Inflammatory gene expression in the lung correlates
with weight loss and viral burden
A primary host response to viral infection is production of
type I interferon (IFN-α/β). To examine if type I interferon is
linked with viral burden or weight loss, lung RNA was analyzed
by qRT-PCR. Indeed, IFN-β and IL-27 (another STAT1 agonist)
expression were strongly positively correlated with viral burden
in the lung (Figure 5A,E). Further, IFN-β and IL-27 production
negatively correlated with starting weight percentage (Figure
5B, data not shown). Our laboratory has recently shown that
IL-17 plays a critical role in lung injury induced by influenza
virus [28]. TH17 pathway cytokines (IL-17, IL-22, and IL-23)
were examined by qRT-PCR. IL-17 gene expression was
Figure 1.  Influenza virus induces variable weight loss and inflammation in outbred mice.  Diversity outbred mice were
infected with 1x106 pfu of influenza A/California/07/2009 virus and were harvested five days later. A, weight loss over time as
percentage of pre-challenge starting weight (N=30). B, correlation between starting weight and weight loss percentage (N=30). C,
bronchoalveolar lavage cell counts correlated with weight loss percentage (N=14). D, bronchoalveolar lavage protein concentration
correlated with weight loss percentage (N=14). R, Pearson’s Rho; P indicates significance as listed. Solid bar indicates group mean.
doi: 10.1371/journal.pone.0082865.g001
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poorly detected in lung RNA at day five post-infection (data not
shown). IL-23 expression significantly correlated with viral
burden and starting weight percentage (Figure 5C,D). In
addition, IL-22 expression positively correlated with viral
burden, but not weight loss (Figure 5F). These data
demonstrate that inflammatory cytokine gene expression can
be correlated with both viral burden and weight loss during
influenza virus infection.
Inflammatory cytokines in the lung correlate with
morbidity later during infection
Since no correlation between lung cytokines and weight loss
or viral burden were found at day five post infection, we
followed another set of mice for eight days post infection and
examined inflammatory cytokines in the lung homogenate.
Eight days after infection there was no correlation between
BAL inflammation and weight loss, similar to findings at day
five. However, at day eight, a broad range of cytokines and
chemokines correlated with weight loss. A highly significant
negative correlation was observed between starting weight
percentage and chemokines, such as MIP-1α, CXCL9,
CXCL10, MCP-1, and KC (data not shown). These chemokines
were most elevated in mice that lost the most weight. In
addition, we detected significant negative correlation with TNF-
α, G-CSF, and IL-6 (Figure 6). These data identify cytokine
biomarkers of worsened disease morbidity during influenza A
virus infection. Influenza viral burden significantly positively
correlated with TNF-α, G-CSF, IL-6, MIP-1α, CXCL10, MCP-1,
and KC (data not shown). This finding demonstrates a
relationship between persistent lung inflammation and elevated
viral burden during infection.
Generation of a novel mouse model of S. aureus
pneumonia and influenza virus co-infection
Since the majority of mortality observed in previously healthy
individuals infected with influenza virus involves bacterial co-
infection, we first established a novel model of S. aureus
pneumonia in JDO mice. Mice were challenged with S. aureus
(USA300, 108 cfu, intranasally) for forty-eight hours. S. aureus
induced variable weight loss in outbred mice (Figure 7A).
Weight loss and bacterial burden in the lung trended to, but did
not significantly correlate (Figure 7B). These data indicate the
JDO model likely provides a broad range of phenotypes in
response to S. aureus challenge, similar to influenza virus
infection.
Our laboratory has recently published an influenza virus, S.
aureus co-infection model [12]. Mice were infected with
influenza (pandemic H1N1 CA/07/2009, 1x106 pfu) virus for 6
days, then they were challenged with S. aureus (USA300, 108
cfu, intranasally) for 2 additional days. On day eight, tissues
were harvested and bacterial colonization of the lung was
determined by plating lung homogenate and colony counts.
JDO mice challenged with only S. aureus had relatively low
lung colony counts (ranging from 0 to 5.7 x 102 CFU/ml), while
co-infected mice had significant exacerbation of bacterial
burden (Figure 7C). In co-infected mice, weight loss and
bacterial burden significantly correlated (Figure 7D). These
data demonstrate a variable phenotype in response to co-
infection, with some mice having high bacterial load following
influenza virus infection, while others with substantially lower
burden.
Figure 2.  Viral burden correlates with weight loss in outbred mice.  Diversity outbred mice were infected with 1x106 pfu of
influenza A/California/07/2009 virus and were harvested five or eight days later. A, day five influenza virus M protein gene
expression (determined by qRT-PCR) correlated with weight loss percentage (N=13). B, day eight influenza virus M protein gene
expression correlated with weight loss percentage (N=13). R, Pearson’s Rho; P indicates significance as listed.
doi: 10.1371/journal.pone.0082865.g002
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Figure 3.  Variable lung pathology in influenza virus infected outbred mice.  Diversity outbred mice were infected with 1x106
pfu of influenza A/California/07/2009 virus and were harvested five days later. A, B, individual mice with similar influenza viral
burden (relative M protein gene expression, lower number) but disparate weight loss (weight loss percentage, upper number). C, D,
individual mice with similar weight loss but different viral burdens. E, individual mouse with extreme weight loss and high viral
burden, but with minimal lung inflammation pathology. F, individual mouse with no weight loss and low viral burden, but with
significant lung injury. G, histologic scoring of lung parenchymal inflammation.
doi: 10.1371/journal.pone.0082865.g003
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Figure 4.  Inflammatory cytokine levels correlated with influenza viral burden or weight loss.  Diversity outbred mice were
infected with 1x106 pfu of influenza A/California/07/2009 virus and were harvested five days later. A, cytokine levels in lung
homogenate (by Lincoplex) correlated with influenza virus M protein gene expression (by qRT-PCR) (N=13). B, cytokine levels in
serum correlated with influenza virus M protein gene expression (N=14). C, D, cytokine levels in serum correlated with weight loss
percentage (N=14). R, Pearson’s Rho; P indicates significance as listed.
doi: 10.1371/journal.pone.0082865.g004
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Figure 5.  Cytokine gene expression correlated with influenza viral burden or weight loss.  Diversity outbred mice were
infected with 1x106 pfu of influenza A/California/07/2009 virus and were harvested five days later. A, C, E, F, influenza virus M
protein gene expression correlated with cytokine expression (by qRT-PCR) (N=13). B, D, weight loss percentage correlated with
cytokine expression (N=13). R, Pearson’s Rho; P indicates significance as listed.
doi: 10.1371/journal.pone.0082865.g005
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Lung histopathology demonstrates a broad range of S.
aureus infection phenotypes
Since JDO mice infected with S. aureus showed differential
weight loss and bacterial burden, we examined lung pathology
in these mice. Similar degrees of low weight loss were
characterized by very different amount of lung inflammation
(Figure 8A,B). A range of diffuse inflammation to little or no
inflammation was observed. Further, severe inflammation was
seen in a mouse with low bacterial burden (Figure 8C) and low
levels of inflammation were present in a mouse with relatively
high weight loss (Figure 8D). These examples illustrate a broad
spectrum of lung pathology phenotypes in the JDO mouse
model.
Lung cytokine production correlates with weight loss
and bacterial burden
Analysis of cytokines in lung homogenate from S. aureus
infected mice revealed numerous correlations between weight
loss and cytokine concentration. Once again, we detected that
elevation of chemokines MIP-2, CXCL9, CXCL10, MIP-1α and
KC (data not shown) significantly correlated with increased
weight loss. In addition, IL-6, IL-1β, TNF-α, and G-CSF
significantly correlated with decreased starting weight (Figure
9A,C,E,F). These data confirm that increased inflammatory
mediators correlate with increased weight loss. Further, both
IL-1β and G-CSF (as well as CXCL9 and MIP-1α, data not
shown) positively correlated with bacterial burden (Figure
9B,D). These data identified several inflammatory mediators
that track with both morbidity and bacterial burden during S.
aureus lung infection.
Figure 6.  Inflammatory cytokine levels correlated with influenza virus induced weight loss at day eight.  Diversity outbred
mice were infected with 1x106 pfu of influenza A/California/07/2009 virus and were harvested eight days later. A-C, weight loss
percentage correlated with lung homogenate cytokine concentration (by Lincoplex) (N=12). R, Pearson’s Rho; P indicates
significance as listed.
doi: 10.1371/journal.pone.0082865.g006
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Lung cytokine production correlates with weight loss
and viral burden in an influenza virus, S. aureus co-
infection model
In our co-infection model described above, weight loss did
not significantly correlate with BAL inflammatory cells, similar to
influenza virus or S. aureus infection alone (data not shown).
Further, in the context of co-infection, viral burden and weight
loss did not significantly correlate (data not shown). To
determine inflammatory markers of severity, we examined
cytokine levels in influenza A virus, S. aureus co-infected mice.
Interestingly, we detected only one cytokine, IL-1β that was
significantly positively correlated with starting weight
percentage (Figure 10A). These data demonstrate that
elevated IL-1β levels correlate with less morbidity during co-
infection, suggesting a protective role for IL-1β in this model.
Indeed, our previous work has demonstrated that preceding
influenza virus infection attenuates the IL-1β responses to S.
aureus alone in inbred mice perhaps increasing susceptibility
[12].
Lung cytokines during co-infection did not significantly
correlate with bacterial burden in the lung unlike the data with
S. aureus infection alone (data not shown). Similar to day eight
influenza virus infected mice alone, co-infected mice displayed
correlation between cytokine levels and viral burden in co-
infected animals. Influenza viral burden significantly positively
correlated with G-CSF, IL-10, MIP-1α, CXCL9, CXCL10,
Figure 7.  Influenza virus, S. aureus co-infection results in variable bacterial burden in outbred mice.  Diversity outbred mice
were infected with 1x106 pfu of influenza A/California/07/2009 virus or vehicle control followed by infection with S. aureus USA300
on day 6 and then harvested 2 days later. A, weight loss induced by S. aureus infection alone in outbred mice (N=15). B, weight
loss induced by S. aureus alone correlated with bacterial burden in lung homogenate (N=15). C, bacterial burden in the lungs of S.
aureus only and co-infected mice (N=15, 12). D, weight loss induced by S. aureus, influenza virus co-infection correlated with
bacterial burden in lung homogenate (N=12). R, Pearson’s Rho; P indicates significance as listed. Solid bar indicates group mean.
doi: 10.1371/journal.pone.0082865.g007
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MCP-1, and KC production (Figure 10B-D, data not shown).
Analysis of lung histopathology demonstrated a wide range of
lung injury phenotypes. These included severe parenchymal
inflammation in a mouse with high weight loss and viral burden
(Figure 10E) and a mouse with no weight loss and low viral
burden (Figure 10F). This illustrates the severity of lung
phenotype in co-infection despite differences in morbidity which
may reflect variable responses to these pathogens in humans.
Discussion
In this study, we demonstrate the utility of using a novel
outbred mouse line to study the molecular phenotype of viral
and bacterial pneumonia severity. By using a genetically
diverse animal population, we can make correlative inferences
relating to the hallmarks of severe disease pathogenesis. This
approach is particularly useful to define determinants, or
biomarkers, of severe disease that may relate to morbidity and
mortality. It is also possible to gain mechanistic insight into
immune host defense pathways by examining markers of
improved clearance or decreased morbidity. Herein, we
demonstrate that influenza virus causes a broad range of
disease phenotypes in outbred mice in terms of weight loss
(morbidity), inflammation, and tissue injury. Thus, this model
reproduces many of the hallmarks of influenza illness in human
populations. Interestingly, we found a significant correlation
between animal weight and eventual weight loss. Larger
animals lost less weight than smaller mice suggesting that
stature and/or frailty may impact disease outcome. It is known
in humans that the very young and elderly are often most
Figure 8.  S. aureus infection results in variable lung pathology in outbred mice.  Diversity outbred mice were infected S.
aureus USA300 and then harvested 2 days later. A-D, lung pathology from individual mice with weight loss percentage (upper
number) and S. aureus burden (lower number, x103 cfu/ml).
doi: 10.1371/journal.pone.0082865.g008
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Figure 9.  Inflammatory cytokine levels correlated with weight loss or bacterial burden in S. aureus infected mice.  Diversity
outbred mice were infected S. aureus USA300 and then harvested 2 days later. A, C, E, F, weight loss percentage correlated with
cytokine expression in lung homogenate (by Lincoplex) (N=15). B, D, bacterial burden correlated with cytokine expression in lung
homogenate (N=15). R, Pearson’s Rho; P indicates significance as listed.
doi: 10.1371/journal.pone.0082865.g009
Novel Model of Pandemic Influenza and Co-Infection
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Figure 10.  Inflammatory cytokine levels correlated with weight loss or viral burden in influenza virus, S. aureus co-
infected mice.  Diversity outbred mice were infected with 1x106 pfu of influenza A/California/07/2009 virus followed by infection with
S. aureus USA300 on day 6 and then harvested 2 days later. A, weight loss percentage correlated with cytokine expression in lung
homogenate (by Lincoplex) (N=12). B-D, influenza virus M protein gene expression correlated with cytokine expression in lung
homogenate (N=12). E, F variable pathology in co-infected individual mice. R, Pearson’s Rho; P indicates significance as listed.
doi: 10.1371/journal.pone.0082865.g010
Novel Model of Pandemic Influenza and Co-Infection
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susceptible to influenza virus induced mortality. We show that
viral burden and morbidity correlate during the infection time
course. Differences in viral burden between outbred mice
exposed to matching inoculum may be due to many factors.
Beyond the immune parameters measured herein, it is
intriguing to speculate that microbiome differences may play a
role in influenza pathogenesis. The role of the microbiome in
directing T cell responses is rapidly emerging. At day five post-
infection, CXCR3 chemokines in serum correlate with morbidity
and viral burden. Interestingly, the degree of lung
histopathologic injury is not directly linked to viral burden or
morbidity. Further, STAT1/2 agonists and TH17 pathway gene
expression correlate with both morbidity and viral burden. Later
during infection, day eight, many inflammatory cytokines
correlate with weight loss and viral burden suggesting that
persistent cytokine production only occurs in severe disease.
During the recent novel H1N1 pandemic several studies
were conducted in an attempt to analyze serum cytokines in
relationship to disease severity [29-31]. The primary consistent
finding in these studies was a positive correlation between IL-6
levels and influenza severity. Our mouse study also identified
persistent IL-6 production to be significantly correlated with
increased morbidity. IL-6 has been shown to be important for
influenza virus host defense in mouse models. IL-6 receptor -/-
and IL-6 -/- mice displayed increased neutrophil death,
worsened lung injury, and increased viral persistence
compared to WT mice [32]. Additionally, IL-6 -/- mice had
impaired CD4+ T cell memory responses to influenza virus,
perhaps due to excessive activation of regulatory T cells [33].
These data suggest that blocking IL-6 during influenza virus
infection is not likely to be an effective therapeutic approach.
However, the degree of IL-6 production may be a useful
biomarker of severe disease progression. In addition to IL-6,
human serum studies identified TNF-α to be positively
correlated with influenza severity. Our mouse model also
showed elevated TNF-α significantly correlated with increased
morbidity. These findings further support the usefulness of this
model to study influenza severity. In addition to morbidity, both
IL-6 and TNF-α levels positively correlated with influenza viral
burden. It is likely that persistent inflammation driven by these
pathways is a relevant biomarker for not only pathologic
phenotype, but also viral persistence.
Our study also identified several correlations between
morbidity or viral burden and TH17 pathway cytokines.
Expression of IL-23, a key TH17/IL-17 promoting cytokine was
positively correlated with influenza viral burden and weight
loss. We found a similar expression pattern for IL-22, a
cytokine produced by TH17, and other cells. Further, persistent
G-CSF production in the lung, a pro-neutrophilic cytokine
downstream of IL-17, was positively correlated with both
morbidity and viral burden. IL-17 is known to promote lung
pathology associated with influenza virus infection [28]. In fact,
IL-17 receptor -/- mice were protected from influenza virus
induced weight loss and inflammation, but did not display
impaired viral clearance. These findings were confirmed in a
2009 H1N1 model [34]. Conversely, IL-22 has been shown to
be protective during influenza virus infection [35-37]. In those
studies, IL-22 protects the epithelium from influenza virus
induced cell death and damage, promoting regeneration and
lung repair. It is possible that TH17 pathway activation is
elevated in severe influenza and that IL-17 may be detrimental
while IL-22 is protective.
Assessment of serum cytokines revealed only two
chemokines that significantly correlated with influenza virus
induced morbidity. Interestingly, we found that the CXCR3
ligands, CXCL9 and CXCL10 were related to weight loss and
viral burden. CXCL10 was positively correlated with morbidity
and influenza virus levels, while CXCL9 was negatively
correlated with weight loss. Serum CXCL10 was shown to be
positively correlated with 2009 H1N1 severity in humans [29].
Mouse studies have shown that attenuation of CXCR3 by
either knockout or antibody treatment results in protection
against influenza virus induced morbidity and mortality [38-40].
These data suggest that CXCR3 signaling is critical to lung
pathogenesis during influenza virus infection. Our mouse
model was able to identify this pathway as a biomarker of
severe influenza. Somewhat surprisingly, we did not find a
correlation between lung histopathology and weight loss or viral
burden. It is possible that the host pathologic response to
influenza virus is highly variable due to the combined impact of
many pathways in addition to inflammatory mediators. These
include epithelial injury genes, endoplasmic reticulum and
mitochondrial stress pathways, and apoptotic cascades.
In this study, we also examined production of the STAT1/2
pathway activators; type I interferon and IL-27. We found that
these cytokines positively correlated with viral burden, an
expected finding as they are primary viral host defense genes.
They also significantly correlated with weight loss. The
interferon pathway and its downstream gene targets are well
described in influenza virus infection [41]. Specifically, type I
interferon promotes cytotoxic T cell lytic activity and B cell
responses during influenza virus infection [42,43]. In fact,
influenza virus NS1 protein targets the type I interferon
pathway as a pathogenic mechanism [44]. Work in our
laboratory and others have shown that elevated type I
interferon may play a vital role in increasing the lung’s
susceptibility to secondary bacterial pneumonia [12,13]. During
severe influenza virus infection, elevated type I interferon leads
to exacerbated bacterial infection through suppression of
subsequent Type 17 immunity [12]. While interferon signaling
may be beneficial in response to virus, it may be detrimental in
terms of secondary pneumonia, which often results in poor
outcomes.
In addition to providing a novel viral infection model, outbred
mice were utilized to examine S. aureus lung infection. Similar
to influenza virus infection, outbred mice displayed a variable
phenotype in terms of bacterial burden, weight loss, and lung
injury. We also observed a disjoint between weight loss,
bacterial burden, and lung histopathology. Production of the
pro-inflammatory cytokines IL-6, TNF-α, and G-CSF all
positively correlated with weight loss. G-CSF also positively
correlated with bacterial burden in the lung. As discussed in the
context of influenza virus infection above, these cytokines may
serve as predictive biomarkers of severe bacterial pneumonia.
We also identified IL-1β as having a positive correlation with
weight loss and bacterial burden. Indeed, in a study of human
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community acquired pneumonia, IL-1β was a predictive marker
for bacterial infection [45]. This is consistent with our findings
that IL-1β tracks with bacterial infection and not influenza virus.
In a cutaneous S. aureus infection model, IL-1β -/- mice had
increased bacterial burden and decreased neutrophil
recruitment [46]. Recent work by our group has shown that
IL-1β is critical to host defense against S. aureus lung infection
[47]. Our mouse model once again served as an accurate
representation of the phenotype of human pneumonia.
Finally, we utilized the outbred mouse model to model
influenza virus, S. aureus co-infection. We based our approach
on our previously published inbred mouse work [12].
Interestingly, weight loss and viral burden did not correlate in
co-infection, but bacterial burden and morbidity did correlate. In
the current study, we showed that CXCR3 ligands and G-CSF
positively correlated with viral burden, similar to influenza virus
infection alone. However, cytokine production did not correlate
with bacterial burden as it did in S. aureus infection alone.
These data indicate that the complexity of co-infection may
significantly alter the biomarkers associated with disease
severity. We did show that the ability to generate an IL-1β
response during co-infection negatively correlated with weight
loss, suggesting that IL-1β is protective in this model. We have
previously shown that preceding influenza virus infection
suppresses S. aureus induced IL-1β levels [12]. This finding
implies that mice that retain IL-1β in response to secondary S.
aureus have lower morbidity. IL-1β levels were not detectable
in serum from infected mice suggesting local production at the
site of inflammation. This finding may complicate the use of this
cytokine as a clinical biomarker although the potential to
measure IL-1β in sputum is intriguing. Lung histopathology in
co-infection remains highly variable between animals and
neither bacterial burden nor weight loss are predictive of lung
pathologic injury.
In this study, we present a novel outbred mouse model of
2009 H1N1 infection, S. aureus pneumonia, and co-infection.
The utility of this model is many fold since we can learn about
the molecular determinants of severe disease in a genetically
diverse population. This information can be applied to
designing novel biomarker approaches for human disease. In
addition, we can unravel the mechanisms of inflammation and
lung injury and further understand conserved and disjointed
pathways of disease. For these reasons, the outbred mouse
model can be utilized to address questions about influenza
pathogenesis that are left unanswered by current approaches.
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